
STAAR Surgical Company
STAAR Surgical Company (STAA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · STAA · as of Jun 8, 2026
Key Statistics
Explore STAAR Surgical Company Data
staa stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 15 · Buy rate: 26.7%
The STAA analyst consensus is Hold, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $29.54, representing -3.59% downside from the current price of $30.64.
Competitors & Peers
staa competitorsStock Performance
Full HistoryAbout STAAR Surgical Company
STAAR Surgical Company together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into th…
what is staar surgical company · staa stock overview · staar surgical company company profile · who is staar surgical company ceo · staa NASDAQ · staar surgical company headquarters · staar surgical company business segments
About Stock Overview & Key Data
STAAR Surgical Company (STAA) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NASDAQ since Feb 24, 1992. As of the latest trading session, STAA stock price is $30.64, with a market capitalization of $1.5B. The stock has returned +78.33% over the past 12 months and +32.61% year-to-date.
According to 15 Wall Street analysts, the consensus rating for STAAR Surgical Company stock is Hold, with an average 12-month price target of $29.54. In fiscal year 2026, STAAR Surgical Company reported revenue of $239.4M and net income of -$80.4M. For detailed data — including STAAR Surgical Company revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, STAAR Surgical Company (STAA) stock price is $30.64. The stock is traded on NASDAQ under the ticker symbol STAA. The 52-week range is $15.59 – $35.87.